等待開盤 05-27 09:30:00 美东时间
+4.420
+3.62%
Interim intent to treat ("ITT") analysis from Study 108 supports strong durable clinical remission in moderately to severely active ulcerative colitis ("UC") patients treated with obefazimod Following two to four
05-23 04:07
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary SharesCash runway remains into Q4 2027, supporting continued funding of clinical programs and
05-05 14:36
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its neuroscience and sleep medicine pipeline.
03-31 22:48
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
03-25 10:31
Abivax plans fundraising after June trial data as CEO signals no urgency to sell amid takeover speculation and strong stock momentum.
03-25 01:53
Barclays analyst Etzer Darout maintains Abivax (NASDAQ:ABVX) with a Overweight and raises the price target from $142 to $148.
03-24 22:00
Companies Reporting Before The Bell • Avalo Therapeutics (NASDAQ:AVTX) is likel...
03-23 19:11
今日重点评级关注:HC Wainwright & Co.:维持Altimmune"买入"评级,目标价从12美元升至25美元;BTIG:维持Jade Biosciences"买入"评级,目标价从28美元升至39美元
03-17 11:45
Leerink Partners analyst Faisal Khurshid initiated coverage with a Buy rating o...
03-16 08:36